In today’s recent session, 8.97 million shares of the CARGO Therapeutics Inc (NASDAQ:CRGX) have been traded, and its beta is 0.22. Most recently the company’s share price was $4.66, and it changed around $0.27 or 6.04% from the last close, which brings the market valuation of the company to $214.66M. CRGX at last check was trading at a discount to its 52-week high of $25.45, offering almost -446.14% off that amount. The share price’s 52-week low was $3.00, which indicates that the recent value has risen by an impressive 35.62% since then. We note from CARGO Therapeutics Inc’s average daily trading volume that its 10-day average is 0.36 million shares, with the 3-month average coming to 648.97K.
CARGO Therapeutics Inc stock received a consensus recommendation rating of Hold, based on a mean score of 3.00. If we narrow it down even further, the data shows that 0 out of 6 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 5 recommended CRGX as a Hold, whereas 0 deemed it a Buy, and 1 rated it as Underweight. CARGO Therapeutics Inc is expected to report earnings per share of -0.48 for the current quarter.
CARGO Therapeutics Inc (NASDAQ:CRGX) trade information
Instantly CRGX has been showing a green trend so far today with a performance of 6.04% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 4.75 on recent trading dayincreased the stock’s daily price by 1.89%. The company’s shares are currently down -69.69% year-to-date, but still up 12.99% over the last five days. On the other hand, CARGO Therapeutics Inc (NASDAQ:CRGX) is 2.08% up in the 30-day period. We can see from the shorts that 3.28 million shares have been sold at a short interest cover period of 4.55 day(s).
The consensus price target as assigned by Wall Street analysts is $7, which translates to bulls needing to increase their stock price by 33.43% from its current value. Analyst projections state that CRGX is forecast to be at a low of $7 and a high of $7.
Forecasts for the next quarter put sales growth at 0.00%.
CARGO Therapeutics Inc earnings are expected to increase by 6.36% in 2025, but the outlook is positive 32.19% per year for the next five years.
CRGX Dividends
CARGO Therapeutics Inc’s next quarterly earnings report is expected to be released on 2025-May-08.
CARGO Therapeutics Inc (NASDAQ:CRGX)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 0.66% of CARGO Therapeutics Inc shares, and 104.82% of them are in the hands of institutional investors. The stock currently has a share float of 105.51%. CARGO Therapeutics Inc stock is held by 161.0 institutions, with FMR LLC being the largest institutional investor. By 2024-06-30, it held 15.8659% of the shares, which is about 6.88 million shares worth $112.92 million.
SAMSARA BIOCAPITAL, LLC, with 10.1875% or 4.42 million shares worth $72.51 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Fidelity Select Portfolios-Health Care Portfolio and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund were the top two Mutual Funds as of May 31, 2025 . The former held 1.28 shares worth $5.88 million, making up 2.78% of all outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund held roughly 1.19 shares worth around $5.48 million, which represents about 2.59% of the total shares outstanding.
